Amifostine

Articles · Lactation Safety Information ·

108823002

Articles

Lactation Safety Information

No published evidence of safety
Used to reduce adverse effects of cyclophosphamide, cisplatin and radiotherapy
Very short half-life (8 minutes), and suspension of breastfeeding during chemotherapy and radiotherapy, would eliminate risk from amifostine if breastfeeding resumed (see summary)